AAMU
NVO

Amundi Asset Management US’s Novo Nordisk NVO Stock Holding History

Amundi Asset Management US’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$36.2M Sell
1,075,160
-1,347,118
-56% -$48M 0.03% 511
2020
Q4 		$84.6M Buy
2,422,278
+335,146
+16% +$11.6M 0.07% 284
2020
Q3 		$72.5M Buy
2,087,132
+15,048
+0.7% +$502K 0.08% 261
2020
Q2 		$67.8M Buy
2,072,084
+712,550
+52% +$22.7M 0.08% 254
2020
Q1 		$40.9M Sell
1,359,534
-1,901,444
-58% -$56.6M 0.07% 258
2019
Q4 		$94.4M Buy
3,260,978
+904,688
+38% +$25.1M 0.11% 186
2019
Q3 		$60.9M Sell
2,356,290
-1,447,362
-38% -$36.6M 0.09% 237
2019
Q2 		$97.1M Buy
3,803,652
+1,928,728
+103% +$47.7M 0.08% 192
2019
Q1 		$49M Buy
+1,874,924
New +$46.1M 0.07% 285

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Amundi Asset Management US's NVO Position: Q1 2021 in Review

Amundi Asset Management US reduced its Novo Nordisk (NVO) stake by 56% in Q1 2021, selling an estimated $48M and leaving 1,075,160 shares worth $36.2M. The position accounts for 0.03% of the portfolio, ranked #511.

Amundi Asset Management US first reported a position in NVO in Q1 2019 and has held it in 9 quarters since. The position peaked at $97.1M in Q2 2019. 707 funds tracked by Wall St. Rank hold NVO as of Q1 2021.

  • Amundi Asset Management US held 1,075,160 shares of Novo Nordisk worth $36.2M as of Q1 2021.
  • Amundi Asset Management US sold 1,347,118 Novo Nordisk shares in Q1 2021, an estimated $48M.
  • Novo Nordisk made up 0.03% of Amundi Asset Management US's portfolio in Q1 2021, its #511 holding.
  • Amundi Asset Management US first reported a position in Novo Nordisk in Q1 2019 and has held it in 9 quarters since.
  • Amundi Asset Management US's Novo Nordisk position peaked at $97.1M in Q2 2019.
  • 707 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.